References
- Cho, Y.-H., Jeong, D.-W., Lee, S.-Y., Park, S.-K., Yoon, K.-T., Kim, Y.-J., Lee, J.-K., Lee, Y.-H. (2011). A case of Wilson's disease in patient with mildly elevated liver enzymes. Korean J. Fam. Med., 32 (3), 205–208. DOI: 10.4082/kjfm.2011.32.3.205.10.4082/kjfm.2011.32.3.205338312522745856
- European Association for the Study of the Liver (2012). EASL Clinical Practice Guidelines: Wilson’s disease. J. Hepatol., 56 (3), 671–685. DOI: 10.1016/j.jhep.2011.11.007.10.1016/j.jhep.2011.11.00722340672
- Fabregues, O. De., Viñas, J., Palasí, A., Quintana, M., Cardona, I., Auger, C., Vargas, V. (2020). Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain Behav., 10 (5), e01596. DOI:10.1002/brb3.1596.10.1002/brb3.1596721824732202078
- Ferenci, P., Litwin, T., Seniow, J., Czlonkowska, A. (2015). Encephalopathy in Wilson disease: Copper toxicity or liver failure? J. Clin. Exp. Hepatol., 5 (Suppl 1), S88–S95. DOI: 10.1016/j.jceh.2014.09.002.10.1016/j.jceh.2014.09.002444286226041965
- Hayashi, H., Watanabe, K., Inui, A., Kato, A., Tatsumi, Y., Okumura, A., Fujisawa, T., Kato, K. (2019). Alanine aminotransferase as the first test parameter for Wilson's disease. J. Clin. Transl. Hepatol., 7 (4), 293–296. DOI:10.14218/JCTH.2019.00042.10.14218/JCTH.2019.00042694321631915597
- Kalita, J., Kumar, V., Misra, U. K., Parashar, V., Ranjan, A. (2019). Adjunctive antioxidant therapy in neurologic Wilson's disease improves the outcomes. J. Mol. Neurosci., 70 (3), 378–385. DOI: 10.1007/s12031-019-01423-8.10.1007/s12031-019-01423-831773400
- Litwin, T., Dusek, P., Szafrański, T., Dziezyc, K., Czlonkowska, A., Rybakowski, J. K. (2018). Psychiatric manifestations in Wilson's disease: Possibilities and difficulties for treatment. Ther. Adv. Psychopharmacol., 8 (7), 199–211. DOI: 10.1177/2045125318759461.10.1177/2045125318759461602288129977520
- Palumbo, C. S., Schilsky, M. L. (2019). Clinical practice guidelines in Wilson disease. Ann. Transl. Med., 7 (Suppl 2), S65. DOI: 10.21037/atm.2018.12.5310.21037/atm.2018.12.53653164531179302
- Roberts, E. A., Schilsky, M. L. (2008). American Association for Study of Liver Disease. Diagnosis and treatment of Wilson disease: An update. Hepatology, 47, 2089–2111. DOI:10.1002/hep.22261.10.1002/hep.2226118506894
- Woimant, F., Djebrani-Oussedik, N., Collet, C., Girardot, N., Poujois, A. (2018). The hidden face of Wilson's disease. Rev. Neurol. (Paris), 174 (9), 589–596. DOI: 10.1016/j.neurol.2018.08.001.10.1016/j.neurol.2018.08.00130249412
- Yu, X.-E., Pan, M., Han, Y.-Z., Yang, R.-M., Wang, J., Gao, S. (2019). The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth, 19, 522. DOI: 10.1186/s12884-019-2641-8.10.1186/s12884-019-2641-8693361831878905
- Zou, J, Wang, Y.-H., Wang, L., Chen, R.-C. (2021). Liver failure of Wilson’s disease with manifestations similar to porphyria and uncommon ATP7B gene mutation: A case report and literature review. Front. Med., 8, 702312. DOI: 10.3389/fmed.2021.702312.10.3389/fmed.2021.702312835005334381801